ASCO and BIO 2024 Preview

May 17, 2024

This preview is rated BD for Business Development.

It’s almost showtime!

The stage is set for the June 3rd ASCO 2024 oral presentation by Dr. Anthony P. Conley on lead EpicentRx therapy, AdAPT-001, in Chicago.

Excitement is also building for the upcoming BIO International Partnering Conference in San Diego from June 3rd-6th where EpicentRx will meet with several interested potential Pharma partners and showcase exciting data with AdAPT-001 and RRx-001 (nibrozetone) in cancer, and neurodegenerative diseases like Parkinson’s and ALS/MND.

So, get ready, we’re less than a week away!